Inventor
SUTTON JONATHAN MARK
GB30 patents
⚠️ This page may combine multiple inventors who share the name “SUTTON JONATHAN MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIESI FARM SPA
8 patentsUS10023558B2Jul 17, 2018
Compounds
CHIESI FARM SPA6 citations83
US9802919B1Oct 31, 2017
Compounds
CHIESI FARM SPA5 citations72
US9409870B2Aug 9, 2016
Compounds
CHIESI FARM SPA5 citations72
US9828382B2Nov 28, 2017
Pyrimidinone compounds as human neutrophil elastase inhibitors
CHIESI FARM SPA0 citations52
US10172830B2Jan 8, 2019
Pyrazolone compounds having human neutrophil elastase inhibitory properties
CHIESI FARM SPA0 citations41
US9868740B2Jan 16, 2018
Pyrimidinone compounds which are HNE inhibitors
CHIESI FARM SPA0 citations41
US9573955B2Feb 21, 2017
Compounds
CHIESI FARM SPA0 citations41
US9487528B2Nov 8, 2016
Compounds
CHIESI FARM SPA0 citations41
CANCER RESEARCH TECH LTD
6 patentsUS11352361B2Jun 7, 2022
Compounds useful as RET inhibitors
CANCER RESEARCH TECH LTD3 citations71
US10954241B2Mar 23, 2021
Heterocyclic compounds as ret kinase inhibitors
CANCER RESEARCH TECH LTD3 citations71
US10844067B2Nov 24, 2020
Heterocyclic compounds as RET kinase inhibitors
CANCER RESEARCH TECH LTD4 citations71
US11680068B2Jun 20, 2023
Compounds useful as RET inhibitors
CANCER RESEARCH TECH LTD1 citations61
US11661423B2May 30, 2023
Heterocyclic compounds as RET kinase inhibitors
CANCER RESEARCH TECH LTD1 citations60
US11548896B2Jan 10, 2023
Heterocyclic compounds as RET kinase inhibitors
CANCER RESEARCH TECH LTD1 citations60
ASTERAND UK LTD
4 patentsUS7803841B2Sep 28, 2010
EP2 receptor agonists
ASTERAND UK LTD11 citations82
US7662839B2Feb 16, 2010
EP2 receptor agonists
ASTERAND UK LTD7 citations72
US7569602B2Aug 4, 2009
Furan derivatives as EP4 receptor antagonists
ASTERAND UK LTD6 citations72
US7417068B2Aug 26, 2008
EP4 receptor antagonists
ASTERAND UK LTD8 citations72
VANDRIA SA
4 patentsUS11820751B2Nov 21, 2023
Urolithin derivatives and methods of use thereof
VANDRIA SA3 citations69
US12473269B2Nov 18, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
US12358884B2Jul 15, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
US12351567B2Jul 8, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58